MA-NETCRACKER-TECHNOLOGY
3.6.2020 14:02:09 CEST | Business Wire | Press release
Netcracker Technology announced today the launch of its Netcracker 2020 portfolio to help service providers focus on their customer’s digital lifestyle. With Netcracker 2020 , service providers can transform customer engagement, dynamically evolve their digital ecosystems and reach new levels of automation and security, helping them to innovate and disrupt in the 5G digital economy.
Netcracker 2020 Digital BSS /OSS and Customer Engagement products and services have been redesigned and enhanced for the 5G era. The new digital portfolio is fully open and standards compliant, built for the cloud and allows service providers to develop their own enhancements or co-develop functions through a low code platform and blueprint delivery approach. With continuous short releases using Agile/DevOps processes, service providers gain faster access to innovative features with no disruptions to business operations. Central to Netcracker 2020 is an industry-leading security framework, designed to provide the highest level of proven system-wide security and privacy, which is critical in an era of increased cyber-attacks, intrusion and disruption.
In addition, as the world prepares for the uncertainty of a post COVID-19 environment, service providers want to increase the effectiveness of remote consumer and business interactions. With Netcracker 2020, they can radically transform customer engagement by anticipating their needs using AI-driven contextual interactions that go beyond problem solving and deliver relevant new services that combine service providers’ own services with those from partners and enriched with 5G experiences. As customers’ requirements become even more of a priority for service providers, personalized offerings can be dynamically created and delivered with a ground-breaking gaming-style user experience and cross-partner loyalty schemes.
Evolving to a more partner-based digital economy will require management of complex relationships, interconnections and business models with new and constantly changing partners, including other service providers. Netcracker 2020 helps build dynamic digital ecosystems that quickly adapt to changing business and market needs. With automated onboarding, simplified lifecycle management and partner-centric B2B2X opportunities, service providers will become both leaders and enablers of new platform-based monetization opportunities in diverse markets.
As services, networks and partnerships become more complex, full automation at every level has become a necessity. Netcracker 2020 uses a new operational model to remove manual tasks and drive hyper automation across network domains, services that cross domains, business processes and channels that are quickly moving towards open 5G networks with cloud-native functions and highly demanding edge cloud applications. Netcracker 2020 digital applications are cloud-native and designed to run in a multicloud environment, delivering the same high performance and resiliency on public clouds as on-premise cloud platforms. This also includes a security architecture and trust center that has become the industry benchmark.
“As BSS/OSS becomes increasingly critical to assure customer experience and enable security and flexible services, Netcracker has strengthened its position as the leader in helping service providers succeed in the highly competitive digital economy,” noted Sue Rudd, Director Networks and Service Platforms at Strategy Analytics. “Netcracker 2020 offers service providers a highly automated, multi-vendor microservices based environment to address their customers’ dynamic digital needs and sets the benchmark for modern BSS/OSS to accelerate revenue-generating service delivery in today’s uncertain world.”
“Netcracker 2020 is the culmination of over 25 years of experience of providing and operating mission-critical systems to hundreds of service providers around the globe in order to keep their businesses moving forward,” said Bob Titus, Chief Technology Officer, Netcracker. “This includes support for new business models, hyper automation, cloud adoption and the use of open source, outcome-based delivery models and, perhaps most importantly, an exceptional digital-first customer experience.”
About Netcracker Technology
Netcracker Technology, a wholly owned subsidiary of NEC Corporation, offers mission-critical digital transformation solutions to service providers around the globe. Our comprehensive portfolio of software solutions and professional services enables large-scale digital transformations, unlocking the opportunities of the cloud, virtualization and the changing mobile ecosystem. With an unbroken service delivery track record of more than 25 years, our unique combination of technology, people and expertise helps companies transform their networks and enable better experiences for their customers.
For more information, visit www.netcracker.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200603005135/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
